Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New androgen receptor ligands described by Bayer Schering Pharma

April 6, 2011

Navitoclax enhances efficacy of taxanes in models of NSCLC

April 6, 2011

RRx-001 to enter clinic as chemotherapeutic/radiosensitizer for cancer

April 6, 2011

New PTEN/TP53/RB1 triple knockout model described of high-grade astrocytoma

April 6, 2011

MK-2206 advances to phase II testing in breast cancer

April 6, 2011

Morphotek acquires tumor-targeting peptide platform from TransMolecular

April 5, 2011

Pan-Akt inhibitor GDC-0068 demonstrates in vivo antitumor effects

April 5, 2011

New inhibitors of cyclin-dependent kinase 9 patented by Novartis

April 5, 2011

Novel microtubule-disrupting agents claimed

April 5, 2011

Glenmark Pharma begins IND-enabling studies for GBR-401

April 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...